Rapid molecular profiling is essential to optimize patient outcomes - Real-world data analysis
sponsored by Thermo Fisher Scientific
November 30, 2023 - 5pm CET
In their retrospective study Integra Connect investigated how this behavior affects outcomes. In this webinar Jeffrey A. Scott, MD, will present the methods, collected data and results, leading to the following conclusion: For patients harboring AODs in advanced NSCLC, initial treatment before receipt of genomic test results yields significantly inferior outcomes and should be avoided.